文献速递泌尿男性生殖肿瘤

NKX3.1定位于线粒体抑制前列腺癌发生

NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.
PubMed 文献 · Cancer Discov · 2021-04-23

本研究整合基因工程小鼠模型、人前列腺癌细胞及类器官培养,发现氧化应激下NKX3.1经伴侣蛋白HSPA9导入线粒体,调控线粒体编码电子传递链基因转录,恢复氧化磷酸化并抑制肿瘤发生。与癌症风险相关的NKX3.1种系多态性丧失保护功能;NKX3.1与线粒体ETC基因低表达与不良预后相关,线粒体NKX3.1高表达与良好预后相关。

要点

  • NKX3.1经HSPA9进入线粒体调控ETC基因转录,恢复氧化磷酸化抑制前列腺癌发生。
  • 增加癌症风险的NKX3.1种系多态性无法保护氧化应激或抑制致瘤性。
  • NKX3.1及线粒体ETC基因低表达与不良预后相关,线粒体NKX3.1高表达与良好预后相关。

核心结论

  • NKX3.1具有非核功能,通过保护线粒体功能抑制前列腺癌发生。

研究设计与样本

  • 整合基因工程小鼠模型、人前列腺癌细胞及人前列腺癌类器官培养的分析。

主要发现

  • 氧化应激下NKX3.1经伴侣蛋白HSPA9导入线粒体,调控线粒体编码电子传递链基因转录,恢复氧化磷酸化并防止癌症发生。
  • 与癌症风险增加相关的NKX3.1种系多态性不能保护免受氧化应激或抑制致瘤性。
  • NKX3.1低表达合并线粒体ETC基因低表达与不良临床结局相关,线粒体NKX3.1蛋白高表达与良好结局相关。

临床怎么用

  • 分析NKX3.1表达水平及亚细胞定位可能改善进展风险患者的风险评估,尤其适用于主动监测男性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mitochondria provide the first line of defense against the tumor-promoting effects of oxidative stress. Here we show that the prostate-specific homeoprotein NKX3.1 suppresses prostate cancer initiation by protecting mitochondria from oxidative stress. Integrating analyses of genetically engineered mouse models, human prostate cancer cells, and human prostate cancer organotypic cultures, we find that, in response to oxidative stress, NKX3.1 is imported to mitochondria via the chaperone protein HSPA9, where it regulates transcription of mitochondrial-encoded electron transport chain (ETC) genes, thereby restoring oxidative phosphorylation and preventing cancer initiation. Germline polymorphisms of NKX3.1 associated with increased cancer risk fail to protect from oxidative stress or suppress tumorigenicity. Low expression levels of NKX3.1 combined with low expression of mitochondrial ETC genes are associated with adverse clinical outcome, whereas high levels of mitochondrial NKX3.1 protein are associated with favorable outcome. This work reveals an extranuclear role for NKX3.1 in suppression of prostate cancer by protecting mitochondrial function. SIGNIFICANCE: Our findings uncover a nonnuclear function for NKX3.1 that is a key mechanism for suppression of prostate cancer. Analyses of the expression levels and subcellular localization of NKX3.1 in patients at risk of cancer progression may improve risk assessment in a precision prevention paradigm, particularly for men undergoing active surveillance.See related commentary by Finch and Baena, p. 2132.This article is highlighted in the In This Issue feature, p. 2113.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Papachristodoulou A, Rodriguez-Calero A, Panja S, et al. NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation. Cancer Discov. 2021. PMID: 33893149. doi:10.1158/2159-8290.CD-20-1765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。